SME Times is powered by   
Search News
Just in:   • Amazon’s $48 billion investment in India to create new opportunities for youth: PM Modi  • "A Call for AI Democracy: Nadella Warns Against Concentrated Power"  • The 45-Day Trap: Why a Well-Intentioned Policy is Backfiring on Our MSMEs  • EAM Jaishankar, South Korea's National Security Director Wi Sung-lac hold talks  • Vietnam values and gives high priority to ties with India: Vietnam National Assembly Chairman 
Last updated: 12 Mar, 2025  

pharma1.jpg India ranked 11th in global pharma exports in 2023: Centre

pharma1.jpg
   Top Stories
» Amazon’s $48 billion investment in India to create new opportunities for youth: PM Modi
» 11th BRICS Energy Ministers' meet to be held in Gurugram today
» PM Modi reviews Rs 30,000-crore infra projects, stresses faster execution
» MSMEs need protection, not just promotion: Report
» Gold, silver trade nearly 2 pc lower amid global interest rates concerns
IANS | 12 Mar, 2025

With the government taking several measures to ensure the quality, safety and efficacy of medicines, the Indian pharmaceutical exports ranked 11th globally in value terms in the year 2023, Anupriya Patel, Union Minister of State for Chemicals and Fertilisers, said in the Rajya Sabha on Tuesday.

Citing a research analysis published by Bain and Company in the year 2025, Patel said that the total pharmaceutical exports accounted for 3 per cent.

“The Central Drugs Standard Control Organisation (CDSCO) and the Ministry of Health and Family Welfare have taken several measures to ensure the quality, safety, and efficacy of medicines,” Patel said, in a written reply.

This includes risk-based inspections of drug manufacturing and testing firms in December 2022 by the CDSCO, in collaboration with State regulators.

About “905 units have been inspected, resulting in 694 actions being taken,” the minister added.

Meanwhile, the MoS also stated that the National Pharmaceuticals Pricing Policy (NPPP), 2012 has laid down principles for the regulation of prices of drugs.

“The key principles of regulation of prices under the said policy are -- regulation on the basis of essentiality of drugs, regulation of prices of formulations only, that is, medicines used by consumers and not the upstream products such as bulk drugs or intermediates, and regulation through market-based pricing and not cost-based pricing,” Patel said.

Under the policy, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals (DoP), fixes ceiling prices under the provisions of the Drugs (Prices Control) Order (DPCO), 2013.

For consumer benefit and transparency, the Ministry has also launched NPPA’s mobile app, Pharma Sahi Daam (PSD). It is available for download from the Google Playstore for Android-based devices and from App Store for Apple devices.

Consumers can easily access the brand name, composition, ceiling price, and maximum retail price of drugs from PSD.

Further, all price notifications of formulations for which prices have been fixed or revised are available on NPPA’s website, Patel said.

 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹95.3
₹93.6
UK Pound
₹127.7
₹123.7
Euro
₹110.65
₹106.9
Japanese Yen ₹59.75 ₹57.9
As on 24 Jun, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter